Evidence map›Paper›PMID 32110744›Full record

ArticleJournal of the Endocrine Society2020

A Novel TBX1 Variant Causing Hypoparathyroidism and Deafness.

Malak Alghamdi, Reem Al Khalifah, Doua K Al Homyani, Waleed H Alkhamis, Stefan T Arold, Aishah Ekhzaimy, Mohammed El-Wetidy, Tarek Kashour, Rabih Halwani

Erratum issuedAbstract read
In one paragraph

Article in Journal of the Endocrine Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Hypoparathyroidism with aJCEM case reports · 2026
    Article
  2. Article
  3. Research square · 2026
    Article
  4. Article
  5. Review
  6. Thymic inborn errors of immunity.The Journal of allergy and clinical immunology · 2025
    Review
  7. Review
  8. Article
  9. Review
  10. Craniofacial Phenotypes and Genetics of DiGeorge Syndrome.Journal of developmental biology · 2022
    Review
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Malak AlghamdiMedical Genetic Division, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia.ORCID 0000-0002-8317-5951
Reem Al KhalifahPediatric Endocrinology Division, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia.ORCID 0000-0002-5304-3528
Doua K Al HomyaniPediatric Endocrinology, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Waleed H AlkhamisDepartment of Obstetrics and Gynecology, King Saud University Medical City, Riyadh, Saudi Arabia.ORCID 0000-0003-1774-2388
Stefan T AroldComputational Bioscience Research Center (CBRC), Division of Biological and Environmental Sciences and Engineering (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.ORCID 0000-0001-5278-0668
Aishah EkhzaimyAdult Endocrinology, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Mohammed El-WetidyCollege of Medicine Research Center, King Saud University, Riyadh, Saudi Arabia.
Tarek KashourCardiology Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Rabih HalwaniSharjah Institute for Medical Research (SIMR), Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe TBX1 gene encodes the T-box 1 protein that is a transcription factor involved in development. Haploinsufficiency of the TBX1 gene is reported to cause features similar to DiGeorge syndrome. The TBX1 gene is located within the DiGeorge syndrome region, and studies support that the TBX1gene is responsible for most of the features of the phenotype of hemizygous deletion of chromosome 22q11.2. In this study, we report a family of 4 (a father with 3 children) who presented with congenital hypoparathyroidism and hypocalcemia, facial asymmetry, deafness, normal intelligence, and no cardiac involvement.

methodsWe performed whole genome sequencing, computational structural analysis of the mutants, and gene expression studies for all affected family members.

resultsWhole genome sequencing revealed a paternal inherited novel heterozygous variant, c.1158_1159delinsT p.(Gly387Alafs*73), in the exon 9 isoform C TBX1 gene, causing a loss of nuclear localization sequence (NLS) and transactivation domain (TAD) with no change in gene expression and resulted in a DiGeorge-like phenotype.

conclusionA pathogenic variant in the TBX1 gene exon 9 C that predicted to cause a loss in the NLS region and most of TAD leads to variable features of hypoparathyroidism, distinctive facial features, deafness, and no cardiac involvement. In addition, our report and previous reports indicate the presence of a wide phenotypic spectrum of TBX1 genetic variants and the consistent absence of cardiac involvement in the case of pathogenic variants on exon 9 isoform C TBX1 gene.

Indexed as

DiGeorge syndromehypocalcemiahypoparathyroidismSNHLTBX1 gene

Identifiers

PMID32110744
PMCPMC7041699

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.